About this podcast
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
396 episodes · Levenswetenschappen
BioCentury This Week
Latest episodeEp. 392 - Biotech markets: Pause before the storm?
About this podcast
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Recent episodes
- Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winners6 Oct · 30 min
- Ep. 390 - Live from Amsterdam: Grand Rounds Europe takeaways30 Sept · 34 min
- Ep. 389 - IgA nephropathy, Overton hearing, reverse mergers' new look29 Sept · 37 min
- Ep. 388 - Biotech IPOs, CAR T safety & pharma tariffs22 Sept · 32 min
- Ep. 387 - Psychedelics at FDA, Mike Davis’ CDER & tRNAs15 Sept · 31 min
- Ep. 386 - Novartis misses, pharma deals analysis, MFN carve-outs9 Sept · 35 min
- Ep. 385 - MFN deals, Lilly takeout, FDA pick Overton1 Sept · 36 min
- Ep. 384 - Back to School Special: The global FIH trials race28 Aug · 43 min
- Ep. 383 - Moderna, Genentech obesity deal, Trump's FDA pick25 Aug · 19 min
- Ep. 382 - Summer’s venture wave; drugging beta-catenin; Capricor & FDA18 Aug · 25 min
sharemy.show/en/biocentury-this-week
For a poster or slide.